Article

Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency

2022-06-02

Abstract excerpt

<title>Abstract</title> <p>T-cell immunity is central for the control of COVID-19, in particular in patients incapable to mount a humoral immune response. We previously reported on the favorable safety profile and efficacy in terms of induction of SARS-CoV-2-specific T-cell responses by CoVac-1, a peptide-based T-cell activator, composed of SARS-CoV-2 T-cell epitopes derived from various viral proteins, combined...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5dbfc353-e4e7-5b51-b33d-f05782248c29
DOI: 10.21203/rs.3.rs-1693355/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiencyDOI 10.21203/rs.3.rs-1693355/v1Read

Phase I Trial of a Multi-Peptide COVID-19 Vaccine for the Induction of SARS-CoV-2 T-Cell ImmunitySemantic proximity Read

Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adultsSemantic proximity Read

Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adultsSemantic proximity Read

T cell immunity of the nonadjuvanted HLA-restricted peptide COVID-19 vaccineSemantic proximity Read

Tissue-resident memory CD8 T-cell responses elicited by a single injection of a multi-target COVID-19 vaccineSemantic proximity Read

T-cell immunity induced by a nonadjuvanted HLA-restricted peptide COVID-19 vaccineSemantic proximity Read

Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipientsSemantic proximity Read

SARS-CoV-2 variant B.1.1.7 caused HLA-A2 <sup>+</sup> CD8 <sup>+</sup> T cell epitope mutations for impaired cellular immune responseSemantic proximity Read

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trialSemantic proximity Read

Bioinformatics Prediction and Identification of Sars-Cov-2-Derived Hla-a-Binding T Cell EpitopesSemantic proximity Read

Identification of Cross-Reactive CD8 <sup>+</sup> T Cell Receptors with High Functional Avidity to a SARS-CoV-2 Immunodominant Epitope and Its Natural Mutant VariantsSemantic proximity Read

Strong specific anti-viral responses in pediatric COVID-19 patients in South BrazilSemantic proximity Read